Heme oxygenase-1 in vascular smooth muscle cells counteracts cardiovascular damage induced by angiotensin II

Current Neurovascular Research

Volumn 2, Issue 2, 2005, Pages 113-120

  Morita, Toshisuke ^a   Imai, Tomihiko ^b   Sugiyama, Takao ^c   Katayama, Shigehiro ^b   Yoshino, Gen ^a  

^a TOHO UNIVERSITY   (Japan)

^b SAITAMA MEDICAL UNIVERSITY   (Japan)

^c INSTITUTE FOR ADULT DISEASES   (Japan)

Author keywords

Angiotensin; Arteries; Oxygen; Stress

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; 8 ISOPROSTAGLANDIN F2 ALPHA; ANGIOTENSIN; BILIVERDIN; CARBON MONOXIDE; GENE PRODUCT; HEME; HEME OXYGENASE 1; IRON; REACTIVE OXYGEN METABOLITE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INTIMA PROLIFERATION; ARTICLE; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR DISEASE; CATALYSIS; CELL PROTECTION; CONTROLLED STUDY; CORONARY ARTERY; DNA DAMAGE; GENE FUNCTION; GENE OVEREXPRESSION; GENE THERAPY; HEART MUSCLE CELL; HEART PROTECTION; HIGH SODIUM INTAKE; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; LIPID PEROXIDATION; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; TRANSGENIC MOUSE; URINARY EXCRETION;

ANGIOTENSIN II; ANIMALS; BLOOD PRESSURE; CARDIOVASCULAR SYSTEM; CORONARY VESSELS; DEOXYGUANOSINE; DOSE-RESPONSE RELATIONSHIP, DRUG; HEME OXYGENASE (DECYCLIZING); HEME OXYGENASE-1; HYPERPLASIA; ISOPROSTANES; MEMBRANE PROTEINS; MICE; MICE, TRANSGENIC; MUSCLE, SMOOTH, VASCULAR; MYOCARDIUM; MYOCYTES, CARDIAC; MYOCYTES, SMOOTH MUSCLE; OXIDATIVE STRESS; SODIUM CHLORIDE, DIETARY; TRANSDUCTION, GENETIC; TUNICA INTIMA; VASCULITIS;

EID: 18744410090     PISSN: 15672026     EISSN: None     Source Type: Journal    
DOI: 10.2174/1567202053586848     Document Type: Article

References (37)

1. Abraham, NG. (2003) Heme oxygenase attenuated angiotensin II-mediated increase in cyclooxygenase activity and decreased isoprostane F2alpha in endothelial cells. Thromb Res 110: 305-9.
2. Ando, K, Sato, Y, Fujita, T. (1990) Salt sensitivity in hypertensive rats with angiotensin II administration. Am J Physiol 259: R1012-R1016.
3. Balla, G, Vercellotti, GM, Muller-Eberland, U, Eaton, J, Jacob, HS. (1991) Exposure of endothelial cells to free heme potentiates damage mediated by granulocytes and toxic oxygen species. Lab Invest 64: 648-655.
4. Boring, L, Gosling, J, Cleary, M, Charo, IF. (1998) Decreased lesion formation in CCR2-l- mice reveals a roll for chemokines in the initiation of atherosclerosis. Nature 394: 894-897
5. Botros, FT, Laniado-Schwartzman, M, Abraham, NG. (2002) Regulation of cyclooxygenase- and cytochrome p450-derived eicosanoids by heme oxygenase in the rat kidney. Hypertension 39: 639-644.
6. Capdevila, J, Chacos, N, Werringloer, J, Prough, R, Estrabrook, R. (1982) Liver microsomal cytochrome P-450 and oxidative metabolism of arachidonic acid. Pro Natl Acad Sci USA 78: 5362-5366.
7. Chen, XL, Tummala, PE, Olbrych, MT, Alexander, RW, Medford, RM. (1998) Angiotensin II induced monocyte chemoattractant protein-1 gene expression in r rat vascular smooth muscle cells. Circ Res 83: 952-959.
8. Eisenstein, RS, Garcia-Mayol, D, Pettingell, W, Munro, HN. (1991) Regulation of ferritin and heme oxygenase synthesis in rat fibroblasts by different forms of iron. Proc Natl Acad Sci USA 88: 688-692.
9. Esterbauer, H, Schaur, RJ, Zollner, H. (1991) Chemistry and biochemistry of 4-hydroxynonenal: malonaldehyde and related aldehydes. Free Radic Biol Med 11: 81-128.
10. Dawson, TC, Kuziel, WA, Osahar, TA, Maeda, N. (1999) Absence of CC chemokine receptor-2 reduced atherosclerosis in apolipoprotein E-deficient mice. Atherosclerosis 143: 205-211.
11. Griendling, KK, Minieri, CA, Ollerenshaw, JD, Alexander, RW. (1994) Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res 74: 1141-1148.
12. Haider, A, Olszanecki, R, Gryglewski, R, Schwartzman, ML, Lianos, E, Kappas, A, Nasjletti, A, Abraham, NG. (2002) Regulation of cyclooxygenase by the heme- heme oxygenase system in microvessel endotheliai cells. J Pharmacol Exp Ther 300: 188-194.
13. Haslinger, A, Karin, M. (1985) Upstream promoter element of the human metallothionein-IIA gene can act like an enhancer element. Proc Natl Acad Sci USA 82: 8572-8576.
14. Hayashi, S, Takamiya, R, Yamaguchi, T, Matsumoto, K, Tojo, SJ, Tamatani, T, Kitajima, M, Makino, N, Ishimura, Y, Suematsu, M. (1999) Induction of heme oxygenase-1 suppresses venular leukocyte adhesion elicited by oxidative stress. 1 Role of bilirubin generated by the enzyme. Circ Res 85: 663-671.
15. Hayek, T, Attias, J, Coleman, R, Brodsky, S., Smith, J, Breslow, JL, Keidar, S. (1999) The angiotensin-converting enzyme inhibitor, fosinopril, and the angiotensin II receptor antagonist, losartan, inhibit LDL oxidation and attenuate atherosclerosis: independent of lowering blood pressure in apolipoprotein E deficient mice. Cardiovasc Res 44: 579-587
16. Li, Volti, G, Seta, F, Schwartzman, ML, Nasjletti, A, Abraham, NG. (2003) Heme oxygenase attenuates angiotensin II-mediated increase in cyclooxygenase-2 activity in human femoral endothelial cells. Hypertension 41(3 pt2): 715-9.
17. Imai, T, Morita, T, Shindo, T, Nagai, R, Yazaki, Y, Kurihara, H, Suematsu, M, Katayama, S. (2001) Vascular smooth muscle cell-directed overexpression of heme oxygenase-1 elevates blood pressure through attenuation of nitric oxide- induced vasodilation in mice. Circ Res 89: 55-62.
18. Kaide, JI, Zhang, F, Wei, Y, Jiang, H, Yu, C, Wang, WH, Balazy, M, Abraham, NG, Nasjletti, A. (2001) Carbon monoxide of vascular origin attenuates the sensitivity of renal arterial vessels to vasoconstrictors. J Clin Invest 107: 1163-1171.
19. Kozma, F, Johnson, RA, Zhang, F, Yu, C, Tong, X, Nasjletti A. (1999) Contribution of endogenous carbon monoxide to regulation of diameter in resistance vessels. Am J Physiol 276: R1087-R1094.
20. Liang, Q, Carlson, EC, Donthi, RV, Kralik, PM, Shen, X, Epstein, PN. (2002). Overexpression of metallothionein reduces diabetic cardiomyopathy. Diabetes 51: 174-181.
21. Mazza, F, Goodman, A, Lombardo, G, Vanella, A, Abraham, NG. (2003) Heme oxygenase-1 gene expression attenuates angiotensin /1-mediated DNA damage in endothelial cells. Exp Biol Med (Maywood) 228(5): 576-83.
22. Morita, T, Perrela, MA, Lee, ME, Kourembanas, S. (1995) Smooth muscle cell- derived carbon monoxide is a regulator of vascular cGMP. Pro Natl Acad Sci USA 92: 1457-1479.
23. Morita, T, Kourembanas, S. (1995) Endothelial cell expression of vasoconstrictors and growth factors is regulated by smooth muscle cell-derived carbon monoxide. J Clin Invest 96(6): 2676-82.
24. Morita, T, Mitsialis, SA, Koike, H, Liu, Y, Kourembanas, S. (1997) Carbon monoxide controls the proliferation of hypoxic vascular smooth muscle cells. J Biol Chem 272(52): 32804-9.
25. Poss, KD, Tonegawa, S. (1997) Reduced stress defense in heme oxygenase 1- deficient cells. Proc Natl Acad Sci USA 94: 10925-10930.
26. Rajagopalan, S, Kurz, S, Munzel, T, Tarpey, M, Freeman, BA, Griendling, KK, and Harrison, DG. (1996) Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation: contribution to alterations of vasomotor tone. J Clin Invest 97: 1916-1923.
27. Rollins, BJ, Morrison, ED, Stiles, CD. (1988) Cloning and expression of JE, a gene inducible by platelet-derived growth factor and whose product has cytokine-like properties. Proc Natl Acad Sci USA 85: 3738-3742.
28. Rueckschloss, U, Quinn, MT, Holtz, J, Morawietz, H. (2002) Dose-dependent regulation of NAD(P)H oxidase expression by angiotensin II in human endothelial cells: Protective effect of angiotensin II type 1 receptor blockade in patients with coronary artery disease. Arterioscler Thromb Vasc Biol 22: 1845-1851.
29. Schmidt-Ott, KM, Kagiyama, S, Phillips, MI. (2000) The multiple actions of angiotensin II in atherosclerosis. Regul Pept 93: 65-77.
30. Shimosawa, T, Shibagaki, Y, Ishibashi, K, Kitamura, K, Kangawa, K, Kato, S, Ando, K, Fujita, T. (2002) Adrenomedullin, an endogenous peptide, counteracts cardiovascular damage. Circulation 105(1): 106-11.
31. Shinoda, Y, Suematsu, M, Vlidkabayashi, V, Suzuki, T, Goda, N, Saito, S, Yamaguchi, T, Ishimura, Y. (1998) Carbon monoxide as a regulator of bile canalicular contractility in cultured rat hepatocytes. Hepatology. 28: 286-295.
32. Stocker, R, Yamamoto, Y, McDonagh, AFt, Glazer, AN, Ames, BN. (1987) Bilirubin is an antioxidant of possible physiological importance. Science. 235: 1043-1046.
33. Yang, L, Quan, S, Nasjletti, A, Schwartzman, ML, Abraham, NG. (2004) Heme Oxygenase-1 Gene Expression Modulates Angiotensin II-Induced Increase in Blood Pressure. Hypertension 43 (6): 1221-6.
34. Yoshida, TT, Kikuchi, G. (1978) Features of the reaction of heme degradation catalyzed by the reconstituted microsomal heme oxygenase system. J Bio Chem 253: 4230-4236
35. Wu, R, Laplante, MA, De Champlain, J. (2004) Prevention of angiotensin II- induced hypertension, cardiovascular hypertrophy and oxidative stress by acetylsalicylic acid in rats. J Hypertens 22(4): 793-801.
36. Zhang, M, Zhang, BH, Chen, L, An, W. (2002) Overexpression of heme oxygenase-1 protects smooth muscle cells against oxidative injury and inhibits cell proliferation. Cell Research 12(2): 123-132.
37. Zhou, MS, Jaimes, EA, Raij, L. (2004) Inhibition of oxidative stress and improvement of endothelial function by amlodipine in angiotensin II-infused rats. Am J Hypertens 17 (2): 167-71.